EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (AMEX:AIS) a specialty pharmaceutical company focused on improving pharmaceuticals through advanced drug delivery systems, today announced that they have entered into a development agreement with Dr. Reddy’s Laboratories, Inc. for the development of an innovative, topically applied product, using Antares’ ATD Gel platform, targeting specific receptor sites within the skin.
